Back to top
more

PetIQ (PETQ)

(Real Time Quote from BATS)

$30.88 USD

30.88
170,352

+0.01 (0.03%)

Updated Oct 7, 2024 01:02 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy23.68%
2Buy17.55%
3Hold9.21%
4Sell4.93%
5Strong Sell2.36%
S&P50010.96%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

1-Strong Buy of 5 1        

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

B Value A Growth C Momentum A VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Top 20% (51 out of 252)

Industry: Medical - Products

Better trading starts here.

Zacks News

Are These Medical Stocks a Great Value Stocks Right Now?

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.

PETQ or BLFS: Which Is the Better Value Stock Right Now?

PETQ vs. BLFS: Which Stock Is the Better Value Option?

Should Value Investors Buy These Medical Stocks?

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.

What's in Store for Perrigo (PRGO) This Earnings Season?

Perrigo's (PRGO) new products as well as products added through acquisitions are expected to have aided the company's top line in the soon-to-be-reported quarter.

AHCO or PETQ: Which Is the Better Value Stock Right Now?

AHCO vs. PETQ: Which Stock Is the Better Value Option?

PetIQ (PETQ) Matches Q3 Earnings Estimates

PetIQ (PETQ) delivered earnings and revenue surprises of 0.00% and 8.02%, respectively, for the quarter ended September 2021. Do the numbers hold clues to what lies ahead for the stock?

PetIQ (PETQ) Reports Next Week: Wall Street Expects Earnings Growth

PetIQ (PETQ) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Petco (WOOF) Down 26% This Year So Far: What Should You Do?

Petco (WOOF) with its omni-channel distribution and a well-diversified product offering is strongly placed in the pet care industry, which is growing rapidly.

Perrigo (PRGO) Stock Up on Irish Tax Bill Settlement Deal

Perrigo (PRGO) agrees to pay an aggregate of approximately $345 million (Euro 297 million) to settle its tax liability notice from the Irish Office of the Revenue Commissioners issued in 2018.

Perrigo (PRGO) to Acquire Another Self-Care Company HRA Pharma

Perrigo (PRGO) offers to acquire HRA Pharma with several leading OTC brands in its portfolio for almost $2.1 billion. The acquisition will complete Perrigo's transformation into a leading self-care company.

Sapna Bagaria headshot

Hold Petco (WOOF) as It Rides on Continued Demand for Pet Care

Petco (WOOF) by dint of its wide product and services portfolio, omni-channel presence and strategic initiatives is well poised to cash in on the expanding petcare industry.

Petco (WOOF) Q2 Earnings Beat on Continued Demand for Pet Care

Petco (WOOF) Q2 earnings exceed estimates on buoyant demand for pet care products and services.

New Strong Sell Stocks for August 11th

FSLY, LGO, PETQ, VLO, and ICAD have been added to the Zacks Rank #5 (Strong Sell) List on August 11, 2021

PetIQ (PETQ) Q2 Earnings and Revenues Miss Estimates

PetIQ (PETQ) delivered earnings and revenue surprises of -10.96% and -11.32%, respectively, for the quarter ended June 2021. Do the numbers hold clues to what lies ahead for the stock?

PetIQ (PETQ) Reports Next Week: Wall Street Expects Earnings Growth

PetIQ (PETQ) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

What's in Store for Perrigo (PRGO) This Earnings Season?

Perrigo's (PRGO) new products as well as products added through acquisitions are expected to have aided the company's top line in the soon-to-be-reported quarter.

NVST vs. PETQ: Which Stock Should Value Investors Buy Now?

NVST vs. PETQ: Which Stock Is the Better Value Option?

QIAGEN (QGEN) Stock Falls on Downbeat Full-Year Guidance

According to QIAGEN (QGEN), stronger-than-expected growth trends were seen in non-COVID product groups in the second quarter of 2021.

NuVasive (NUVA) International Sales Solid Despite COVID-19 Woes

We are upbeat about NuVasive's (NUVA) newly-introduced organizational and leadership structure for its global commercial operations as well as its product and services organization.

Masimo (MASI) Reports Study Findings Backing the SedLine

Masimo (MASI) releases new study findings assessing two parameters provided by the SedLine that exhibit high predictability for mortality 180 days after cardiac arrest.

Medtronic's (MDT) DEFINE AFib Study to Assess AF Burden

Medtronic (MDT) begins first app-based study to understand atrial fibrillation burden in patients, utilizing data collected from the LINQ range of insertable cardiac monitors.

Bio-Rad (BIO)-Seegene Pact to Provide Diagnostic Suit In U.S.

Bio-Rad (BIO) and Seegene team up to develop and commercialize molecular diagnostic products in the United States.

Amedisys' (AMED) Contessa Buyout to Boost Home Health Business

Amedisys (AMED) inks deal to acquire Contessa Health to boost home health and hospice services business.

Abbott (ABT) Reports Late-Breaking Data on FreeStyle Libre

Late-breaking data on Abbott's (ABT) FreeStyle Libre system demonstrates improvement in health and equity outcomes for diabetes patients.

Charles River (CRL) Advances in Gene Therapy With Vigene Buyout

The consolidation between Charles River (CRL) and Vigene is set to establish an end-to-end, gene-modified cell therapy solution in the United States.